-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$5.334.92% Upside
Amylyx Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. has been rated by research analysts at Bank of America Securities, H.C. Wainwright, Leerink Partners, Mizuho Securities, Robert W. Baird, Deutsche Bank in the past 90 days.